In a closely watched ballot measure, Massachusetts voters have decisively turned down a proposal to legalize certain psychedelic substances for therapeutic use and personal cultivation. The initiative, known as Question 4, aimed to decriminalize natural psychedelics like psilocybin mushrooms and mescaline cacti for adults 21 and older. Proponents argued that these substances could offer significant mental health benefits, particularly for conditions such as depression and PTSD. However, opponents, including many medical professionals, expressed concerns about potential health risks and the lack of FDA approval. The rejection of this measure marks a setback for the growing movement to expand access to psychedelic therapies in the United States. Despite this outcome, advocates remain hopeful that ongoing clinical research will continue to explore the potential benefits of these substances in controlled settings.
For more details on this story, visit NPR’s coverage.